Cited by 12Attention Deficit Hyperactivity DisorderDevelopmental and Educational NeuropsychologySchizophrenia research and treatment

Processing speed can monitor stimulant-medication effects in adults with attention deficit disorder with hyperactivity

Nielsen, Niels Peter, Wiig, Elisabeth H., Bäck, Svante, Gustafsson, Jan·2017·Nordic Journal of Psychiatry

Abstract

Background Treatment responses to methylphenidate by adults with ADHD are generally monitored against DSM-IV/DSM-V symptomatology, rating scales or interviews during reviews. Aims To evaluate the use of single- and dual-dimension processing-speed and efficiency measures to monitor the effects of pharmacological treatment with methylphenidate after a short period off medication. Methods A Quick Test of Cognitive Speed (AQT) monitored the effects of immediate-release methylphenidate in 40 previously diagnosed and medicated adults with ADHD. Processing speed was evaluated with prior prescription medication, without medication after a 2-day period off ADHD medication, and with low-dose (10/20 mg) and high-dose (20/40 mg) methylphenidate hydrochloride (Medikinet IR). Results Thirty-three participants responded to the experimental treatments. One-way ANOVA with post-hoc analysis (Scheffe) indicated significant main effects for single dimension colour and form and dual-dimension colour-form naming. Post-hoc analysis indicated statistical differences between the no- and high-dose medication conditions for colour and form, measures of perceptual speed. For colour-form naming, a measure of cognitive speed, there was a significant difference between no- and low-dose medication and between no- and high-dose medications, but not between low- and high-dose medications. Conclusions Results indicated that the AQT tests effectively monitored incremental effects of the methylphenidate dose on…

Integrity signals

Registry

Crossref · 10.1080/08039488.2017.1280534

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals with ADHD who have more severe NPDs experience greater benefits from stimulant medication compared to individuals with ADHD who have less severe NPDs.

    “Prior research has even demonstrated that individuals with ADHD who have more severe NPDs experience greater benefits from stimulant medication compared to individuals with ADHD who have less severe NPDs (Fosco et al., 2021; Nielsen et al., 2017).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Nielsen, N. P., Wiig, E. H., Bäck, S., & Gustafsson, J.
Affiliations
  • Department of Psychiatry, Västervik Sjukhus, Västervik, Sweden;
  • Boston University (US)
  • Medical Department, Evolan Pharma AB, Danderyd, Sweden
Corresponding author
Wiig, Elisabeth H.
Venue
Nordic Journal of Psychiatry
Published
2017-02-07
Volume
71
Issue
4
Pages
296-303
ISSN
  • 0029-1455 (ISSN-L)
  • 0803-9488
  • 1502-4725
OpenAlex
W2586945530
Cited by
12
References
5
Citations by year
2026: 1 · 2024: 1 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 2
FWCI
1.80
Type
journal article
Language
en
Open access
closed
Locations
  • Nordic Journal of Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Funders
EVOLAN PHARMA AB, Danderyd, Sweden (None)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Social Sciences › Psychology › Neuropsychology and Physiological Psychology › Developmental and Educational Neuropsychology
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords
attention deficit hyperactivity disorder, adult ADHD, methylphenidate, processing speed, treatment response monitoring, perceptual speed, processing efficiency, stimulant medication, dose-response relationship
MeSH terms
Adolescent, Adult, Central Nervous System Stimulants, Attention, Attention Deficit Disorder with Hyperactivity, Color Perception, Dose-Response Relationship, Drug, Female, Humans, Male, Methylphenidate, Middle Aged, Neuropsychological Tests, Pattern Recognition, Visual, Reaction Time, Sweden, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review